SP-D polymorphisms and the risk of COPD

Disease Markers

Volumn 33, Issue 2, 2012, Pages 91-100

  Shakoori, Tania A ^a   Sin, Don D ^b   Bokhari, S Nazim Hussain ^a   Ghafoor, Farkhanda ^c   Shakoori, A R ^d  

^a University of Health Science   (Pakistan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SZMC   (Pakistan)

^d UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

COPD risk; serum SP D levels; SP D haplotypes; SP D SNPs; Surfactant protein D

Indexed keywords

BRONCHODILATING AGENT; SURFACTANT PROTEIN D;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE FREQUENCY; GENOTYPE; HEREDITY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SPIROMETRY;

EID: 84864439966     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2012/802145     Document Type: Article

References (41)

1. L. Fromer and C.B. Cooper, A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD, Int J Clin Pract 62 (2008), 1219-1236.
2. R.T. Abboud and S. Vimalanathan, Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema, Int J Tuberc Lung Dis 12 (2008), 361-367.
3. W.MacNee, Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease, Proc Am Thorac Soc 2 (2005), 50-60.
4. J.C. Hogg, Pathophysiology of airflow limitation in chronic obstructive pulmonary disease, Lancet 364 (2004), 709-721.
5. K. Imai, B.A. Mercer, L.L. Schulman, et al., Correlation of lung surface area to apoptosis and proliferation in human emphysema, Eur Respir J 25 (2005), 250-258.
6. S. Grumelli, D.B. Corry, L.Z. Song, et al., An immune basis for lung parenchymal Destruction in chronic obstructive pulmonary disease and emphysema, PLoS Med 1 (2004), 75-83.
7. M.G. Cosio, Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstuctive pulmonary disease. Eur Respir J 24 (2004), 3-5.
8. B.G. Cosio, L. Tsaprouni, K. Ito, et al., Theophylline restores histone Deacetylase activity and steroid responses in COPD macrophages, J Exp Med 200 (2004), 689-695.
9. W. MacNee, Accelerated lung aging: A novel pathogenic mechanismof chronic obstructive pulmonary disease (COPD), Biochem Soc Trans 37 (2009), 819-823.
10. P.J. Boron, E.A. Mostaghel, C. Doyle, et al., Pulmonary surfactant protein A and D directly suppress CD3(+)/CD4(+) cell function: Evidence for two shared mechanisms, J Immunol 169 (2002), 5844-5850.
11. S.J. Gardai, Y.Q. Xiao, M. Dickinson, et al., By Binding SIRPa or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation, Cell 115 (2003), 13-23.
12. R.W. Vandivier, C.A. Ogden, V.A. Fadock, et al., Role of surfactant proteins A, D and C1q in clearance of apoptotic cells in vivo and in vitro: Calreticulin and CD91 as a common collectin receptor complex, J Immunol 169 (2002), 3978-3986.
13. N. Palaniyar, H. Clark, J. Nadesalingama, et al., Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance in vivo. Apoptosis: From Signaling Pathways, Therapeutic Tools 1010 (2003), 471-475.
14. N. Palaniyar, J. Nadesalingama, H. Clark, et al., Nucleic acid is a novel ligand for innate immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin, J Biol Chem 279 (2004), 32728-32736.
15. N. Palaniyar, H. Clark, J. Nadesalingama, et al., Innate immune collectin surfactant protein D enhances the clearance of DNA by Macrophages and Minimizes Anti-DNA Antibody Generation, J Immunol 174 (2005), 7352-7358.
16. S. DiAngelo, Z. Lin, G. Wang, et al., Novel, Non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles, DisMarkers 15 (1999), 269-281.
17. M. Lahti, J. Lofgren, R. Marttila, et al., Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection, Pediatr Res 51 (2002), 696-699.
18. J. Floros, H.M. Lin,A.Garcia, et al., Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in aMexican population, J Infect Dis 182 (2000), 1473-1478.
19. K.L. Hartshorn, M.R. White, K. Smith et al., Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: Bissociation of mannan-binding and antiviral activity. Scand J Immunol 72 (2010), 22-30.
20. Y.Q. Deng, Z.Z. Tao, Y.G. Kong, et al., Association between single nucleotide polymorphisms of surfactant protein D and allergic rhinitis in Chinese patients, TissueAntigens 73 (2009), 546-552.
21. M.G. Foreman, X. Kong, D.L. DeMeo, et al., Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol 44 (2011), 316-322.
22. E.B. Brandt, M.K.Mingler, M.D. Stevenson, et al., Surfactant protein D alters allergic lung responses in mice and human subjects, J Allergy Clin Immunol 121 (2008), 1140-1147.
23. R. Leth-Larsen, C. Nordenbaek, I. Tornoe, et al., Surfactant D (SP-D) serum levels in patients with community-acquired pneumonia, Clin Immunol 108 (2003), 29-37.
24. M. Tanaka, Y. Arimura, A. Goto, et al., Genetic variants in surfactant, pulmonary-associated protein D (SFTPD) and Japanese susceptibility to ulcerative colitis, Inflamm Bowel Dis 15 (2009), 918-925.
25. N.J. Thomas, S. DiAngelo, J.C. Hess, et al., Transmission of Surfactant Protein Variants and Haplotypes in Children Hospitalized with Respiratory Syncytial Virus, Pediatr Res 66 (2009), 70-73.
26. S. Burge and J.A.Wedzicha, COPD exacerbations: Befinitions and classifications, Eur Respir J 21 (2003), S46-S53.
27. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNAfrom human nucleated cells, Nucleic Acids Research 16 (1988), 1215.
28. M. Krueger, B. Puthothu, E. Gropp, et al., Amino acid variants in Surfactant protein D are not associated with bronchial asthma, Pediatr Allergy Immunol 17 (2006), 77-81.
29. G.L. Srensen, J.B.Hjelmborg, K.O.Kyvik, et al., Genetic and environmental influences of surfactant protein D serum levels, AmJ Physiol Lung Cell Mol Physiol 290 (2006), L1010-1017.
30. Y.Y. Shi and L. He, SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci, Cell Res 15 (2005), 97-98.
31. X.M. Zhao, Y.P. Wu, R. Wei, et al., Plasma surfactant protein D levels and the relation to body mass index in a Chinese population, Scand J Immunol 66 (2007), 71-76.
32. J.M. Ferńandez-Real, S. Vald́es, M. Manco, et al., Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity, Diabetes Care 33 (2010), 847-853.
33. D.A. Lomas, E.K. Silverman, L.D. Edwards, et al., Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD, Eur Respir J 34 (2009), 95-102.
34. T.A. Shakoori, D.D. Sin, F. Ghafoor, et al., Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease, Dis Markers 27 (2009), 287-294.
35. M.W. Sims, R M. Tal-Singer, S. Kierstein, et al., Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: A cross-sectional study. Respiratory Research 9 (2008), 13.
36. D.D. Sin, P.S. Pahlvan and S.F.P. Man, Surfactant protein D: A lung specific biomarker in COPD? Ther Adv Resp Dis 2 (2008), 65-74.
37. G.R. Mason, A.M. Peters, E. Bagdades, et al., Evaluation of pulmonary alveolar epithelial integrity by the Detection of restriction to diffusion of hydrophilic solutes of different molecular sizes, Clin Sci (Lond) 100 (2001), 231-236.
38. E. Prescott, A.M. Bjerg, P.K. Andersen, et al., Gender difference in smoking effects on lung function and risk of hospitalization for COPD: Results from a Danish longitudinal population study, Eur Resp J 10 (1997), 822-827.
39. K. Heidinger, I.R. Konig, A. Bohnert, et al., Polymorphisms in the human surfactant protein-D (SFTPD) gene: Strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced, Immunogenetics 57 (2005), 1-7.
40. M. Mutti, M. Corradi, M. Goldoni, et al., Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma, Chest 129 (2006) 1288-1297.
41. T. Ishii, K. Haqiwara, K. Kamio, et al., Involvemement of surfactant protein D in emphysema revealed by genetic association study, Eur J Hum Genet 2011 Sep 21. doi: 10.1038/ejhg. 2011.183. [Epub ahead of print].